131 related articles for article (PubMed ID: 31702049)
41. HIV-induced T-cell activation/exhaustion in rectal mucosa is controlled only partially by antiretroviral treatment.
Rueda CM; Velilla PA; Chougnet CA; Montoya CJ; Rugeles MT
PLoS One; 2012; 7(1):e30307. PubMed ID: 22276176
[TBL] [Abstract][Full Text] [Related]
42. Prognostic value of the immunological phenomena and relationship with clinicopathological characteristics of the tumor--the expression of the early CD69+, CD71+ and the late CD25+, CD26+, HLA/DR+ activation markers on T CD4+ and CD8+ lymphocytes in squamous cell laryngeal carcinoma. Part II.
Starska K; Głowacka E; Kulig A; Lewy-Trenda I; Bryś M; Lewkowicz P
Folia Histochem Cytobiol; 2011; 49(4):593-603. PubMed ID: 22252753
[TBL] [Abstract][Full Text] [Related]
43. Frequency and functional characterization of exhausted CD8
Taghiloo S; Allahmoradi E; Tehrani M; Hossein-Nataj H; Shekarriz R; Janbabaei G; Abediankenari S; Asgarian-Omran H
Eur J Haematol; 2017 Jun; 98(6):622-631. PubMed ID: 28306177
[TBL] [Abstract][Full Text] [Related]
44. Characterization of regulatory T cells in patients with B-cell chronic lymphocytic leukemia.
Giannopoulos K; Schmitt M; Kowal M; Wlasiuk P; Bojarska-Junak A; Chen J; Rolinski J; Dmoszynska A
Oncol Rep; 2008 Sep; 20(3):677-82. PubMed ID: 18695923
[TBL] [Abstract][Full Text] [Related]
45. Dominant enrichment of phenotypically activated CD38(+) HLA-DR(+) CD8(+) T cells, rather than CD38(+) HLA-DR(+) CD4(+) T cells, in HIV/HCV coinfected patients on antiretroviral therapy.
d'Ettorre G; Ceccarelli G; Serafino S; Giustini N; Cavallari EN; Bianchi L; Pavone P; Bellelli V; Turriziani O; Antonelli G; Stroffolini T; Vullo V
J Med Virol; 2016 Aug; 88(8):1347-56. PubMed ID: 26765625
[TBL] [Abstract][Full Text] [Related]
46. Phenotypic alteration of CD8+ T cells in chronic lymphocytic leukemia is associated with epigenetic reprogramming.
Wu J; Xu X; Lee EJ; Shull AY; Pei L; Awan F; Wang X; Choi JH; Deng L; Xin HB; Zhong W; Liang J; Miao Y; Wu Y; Fan L; Li J; Xu W; Shi H
Oncotarget; 2016 Jun; 7(26):40558-40570. PubMed ID: 27302925
[TBL] [Abstract][Full Text] [Related]
47. Ibrutinib treatment improves T cell number and function in CLL patients.
Long M; Beckwith K; Do P; Mundy BL; Gordon A; Lehman AM; Maddocks KJ; Cheney C; Jones JA; Flynn JM; Andritsos LA; Awan F; Fraietta JA; June CH; Maus MV; Woyach JA; Caligiuri MA; Johnson AJ; Muthusamy N; Byrd JC
J Clin Invest; 2017 Aug; 127(8):3052-3064. PubMed ID: 28714866
[TBL] [Abstract][Full Text] [Related]
48. Chronic lymphocytic leukaemia cells drive the global CD4+ T cell repertoire towards a regulatory phenotype and leads to the accumulation of CD4+ forkhead box P3+ T cells.
Piper KP; Karanth M; McLarnon A; Kalk E; Khan N; Murray J; Pratt G; Moss PA
Clin Exp Immunol; 2011 Nov; 166(2):154-63. PubMed ID: 21985361
[TBL] [Abstract][Full Text] [Related]
49. Increased frequency of CD8+ and CD4+ regulatory T cells in chronic lymphocytic leukemia: association with disease progression.
Jadidi-Niaragh F; Yousefi M; Memarian A; Hojjat-Farsangi M; Khoshnoodi J; Razavi SM; Jeddi-Tehrani M; Shokri F
Cancer Invest; 2013 Feb; 31(2):121-31. PubMed ID: 23286587
[TBL] [Abstract][Full Text] [Related]
50. Intracellular tumor necrosis factor production by T- and B-cells in B-cell chronic lymphocytic leukemia.
Bojarska-Junak A; Rolinski J; Wasik-Szczepaneko E; Kaluzny Z; Dmoszynska A
Haematologica; 2002 May; 87(5):490-9. PubMed ID: 12010662
[TBL] [Abstract][Full Text] [Related]
51. Morphological variants of leukemic cells in B chronic lymphocytic leukemia are associated with different T cell and NK cell abnormalities.
Reyes E; Prieto A; Carrion F; Garcia-Suarez J; Esquivel F; Alvarez-Mon M
Am J Hematol; 1997 Aug; 55(4):175-82. PubMed ID: 9257876
[TBL] [Abstract][Full Text] [Related]
52. The CD28/HLA-DR expressions on CD4+T but not CD8+T cells are significant predictors for progression to AIDS.
Choi BS; Park YK; Lee JS
Clin Exp Immunol; 2002 Jan; 127(1):137-44. PubMed ID: 11882044
[TBL] [Abstract][Full Text] [Related]
53. Relationships between T-lymphocytes and physical function in adults with chronic lymphocytic leukemia: Results from the HEALTH4CLL pilot study.
Crane JC; Gordon MJ; Basen-Engquist K; Ferrajoli A; Markofski MM; Lee CY; Fares S; Simpson RJ; LaVoy EC
Eur J Haematol; 2023 Jun; 110(6):732-742. PubMed ID: 36946440
[TBL] [Abstract][Full Text] [Related]
54. Antigen modulation followed by quantitative flow cytometry of B-chronic lymphocytic leukemia cells after treatment.
Kusenda J; Babusíková O
Neoplasma; 2004; 51(2):97-102. PubMed ID: 15190418
[TBL] [Abstract][Full Text] [Related]
55. Oligoclonal TCRBV gene usage in B-cell chronic lymphocytic leukemia: major perturbations are preferentially seen within the CD4 T-cell subset.
Rezvany MR; Jeddi-Tehrani M; Osterborg A; Kimby E; Wigzell H; Mellstedt H
Blood; 1999 Aug; 94(3):1063-9. PubMed ID: 10419899
[TBL] [Abstract][Full Text] [Related]
56. Difference in the relative distribution of CD4+ T-cell subsets in B-CLL with mutated and unmutated immunoglobulin (Ig) VH genes: implication for the course of disease.
Tinhofer I; Weiss L; Gassner F; Rubenzer G; Holler C; Greil R
J Immunother; 2009 Apr; 32(3):302-9. PubMed ID: 19242370
[TBL] [Abstract][Full Text] [Related]
57. Decrease of T-cells exhaustion markers programmed cell death-1 and T-cell immunoglobulin and mucin domain-containing protein 3 and plasma IL-10 levels after successful treatment of chronic hepatitis C.
Osuch S; Laskus T; Berak H; Perlejewski K; Metzner KJ; Paciorek M; Radkowski M; Caraballo Cortés K
Sci Rep; 2020 Sep; 10(1):16060. PubMed ID: 32994477
[TBL] [Abstract][Full Text] [Related]
58. PD-1 and PD-L1 gene expressions and their association with Epstein-Barr virus infection in chronic lymphocytic leukemia.
Gamaleldin MA; Ghallab OM; Nadwan EA; Abo Elwafa RA
Clin Transl Oncol; 2021 Nov; 23(11):2309-2322. PubMed ID: 34120295
[TBL] [Abstract][Full Text] [Related]
59. HLA-DR expression on regulatory T cells is closely associated with the global immune activation in HIV-1 infected subjects naïve to antiretroviral therapy.
Xiao J; Qian KL; Cao QH; Qiu CL; Qiu C; Xue YL; Zhang XY; Zhong P; Xu JQ; Li MY; Wang Y
Chin Med J (Engl); 2011 Aug; 124(15):2340-6. PubMed ID: 21933566
[TBL] [Abstract][Full Text] [Related]
60. Impact of CD39 expression on CD4+ T lymphocytes and 6q deletion on outcome of patients with chronic lymphocytic leukemia.
Mosaad Zaki E; Mohamed Zahran A; Abdelazeem Metwaly A; Hafez R; Hussein S; Elaiw Mohammed A
Hematol Oncol Stem Cell Ther; 2019 Mar; 12(1):26-31. PubMed ID: 30336122
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
